A combination of three drugs to treat pancreatic cancer

Scientists at the Johns Hopkins Cancer Center have created an "ideal blend" that can eliminate pancreatic cancer.

Read more

"If you have pancreatic cancer, immune T cells are lacking to recognize and eliminate cancer cells."

Now, with great effort, scientists have identified three drugs to form a perfect combination for the treatment of pancreatic cancer.

The researchers say the combination is composed of PancVAX, an antibody-enhancing product with control of anti-PD-1 and OX40 antibodies. After the tests, an increase in the immune response and an increase in the number of T lymphocytes were observed.

Trials should begin clinical trials on patients next year.

Source: MEDIC FORM